Literature DB >> 33738127

Pemberton Osteotomy for Acetabular Dysplasia.

Shier-Chieg Huang1, Ting-Ming Wang1, Kuan-Wen Wu2, Chien-Feng Fang1, Ken N Kuo3.   

Abstract

INTRODUCTION: We have performed open reduction with Pemberton osteotomy, as our primary treatment method for developmental dysplasia of the hip, in more than 550 patients at our institution since 1993. STEP 1 EXPOSURE: With the patient supine, make an anterior iliofemoral incision that is not directly on the iliac crest, dissect the subcutaneous tissue in the line of the incision, expose the iliac crest, and divide the cartilage at the iliac crest. STEP 2 PERFORM ILIOPSOAS TENOTOMY: Identify the rectus femoris tendon, release the iliopsoas muscle, and identify the acetabulum-hip capsule junction. STEP 3 PERFORM OPEN REDUCTION AND OSTEOTOMY: Perform an open reduction, check hip stability, make medial and lateral cut lines, and complete the osteotomy. STEP 4 INSERT ILIAC BONE GRAFT: Harvest the graft, position the reduced hip joint, insert the bone graft, repair the capsule, and close the wound. STEP 5 POSTOPERATIVE MANAGEMENT: Apply a hip spica cast after skin closure. RESULTS & PREOP/POSTOP IMAGES: In our clinical and radiographic review of forty-nine patients followed for more than ten years after treatment of developmental dysplasia of the hip with a unilateral Pemberton osteotomy, there were no redislocations and no patient required additional surgery for residual hip dysplasia after the original Pemberton osteotomy. WHAT TO WATCH FOR: Indications Contraindications Pitfalls & Challenges.
Copyright © 2011 by The Journal of Bone and Joint Surgery, Incorporated.

Entities:  

Year:  2011        PMID: 33738127      PMCID: PMC7821973          DOI: 10.2106/JBJS.ST.K.00003

Source DB:  PubMed          Journal:  JBJS Essent Surg Tech        ISSN: 2160-2204


  10 in total

1.  Injury to the growth plate after Pemberton osteotomy.

Authors:  A I Leet; W G Mackenzie; G Szoke; H T Harcke
Journal:  J Bone Joint Surg Am       Date:  1999-02       Impact factor: 5.284

2.  PERICAPSULAR OSTEOTOMY OF THE ILIUM FOR TREATMENT OF CONGENITAL SUBLUXATION AND DISLOCATION OF THE HIP.

Authors:  P A PEMBERTON
Journal:  J Bone Joint Surg Am       Date:  1965-01       Impact factor: 5.284

3.  One-stage correction of the dysplastic hip in cerebral palsy with the San Diego acetabuloplasty: results and complications in 104 hips.

Authors:  N P McNerney; S J Mubarak; D R Wenger
Journal:  J Pediatr Orthop       Date:  2000 Jan-Feb       Impact factor: 2.324

4.  Dega osteotomy for the treatment of congenital dysplasia of the hip.

Authors:  J S Grudziak; W T Ward
Journal:  J Bone Joint Surg Am       Date:  2001-06       Impact factor: 5.284

5.  The incomplete pericapsular (Pemberton) and innominate (Salter) osteotomies; a complete analysis.

Authors:  S S Coleman
Journal:  Clin Orthop Relat Res       Date:  1974 Jan-Feb       Impact factor: 4.176

6.  Analysis of osteonecrosis following Pemberton acetabuloplasty in developmental dysplasia of the hip: long-term results.

Authors:  Kuan-Wen Wu; Ting-Ming Wang; Shier-Chieg Huang; Ken N Kuo; Chi-Wen Chen
Journal:  J Bone Joint Surg Am       Date:  2010-09-01       Impact factor: 5.284

7.  Pemberton osteotomy for the treatment of developmental dysplasia of the hip in older children.

Authors:  R Vedantam; A M Capelli; P L Schoenecker
Journal:  J Pediatr Orthop       Date:  1998 Mar-Apr       Impact factor: 2.324

8.  Pemberton's acetabuloplasty for congenital dislocation or subluxation of the hip.

Authors:  A L Eyre-Brook; D A Jones; F C Harris
Journal:  J Bone Joint Surg Br       Date:  1978-02

9.  Premature closure of the triradiate cartilage: a potential complication of pericapsular acetabuloplasty.

Authors:  R L Plaster; P L Schoenecker; A M Capelli
Journal:  J Pediatr Orthop       Date:  1991 Sep-Oct       Impact factor: 2.324

10.  Pemberton osteotomy for developmental dysplasia of the hip in older children.

Authors:  Akifusa Wada; Toshio Fujii; Kazuyuki Takamura; Haruhisa Yanagida; Mayuki Taketa; Tomoyuki Nakamura
Journal:  J Pediatr Orthop       Date:  2003 Jul-Aug       Impact factor: 2.324

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.